165 related articles for article (PubMed ID: 25539699)
1. Case files of the Harvard medical toxicology fellowship: valacyclovir neurotoxicity and unintentional overdose.
Huguenel C; Felton D; Bruccoleri R; Salhanick S
J Med Toxicol; 2015 Mar; 11(1):132-6. PubMed ID: 25539699
[No Abstract] [Full Text] [Related]
2. Acute kidney injury due to crystalluria following acute valacyclovir overdose.
Roberts DM; Smith MW; McMullan BJ; Sevastos J; Day RO
Kidney Int; 2011 Mar; 79(5):574. PubMed ID: 21321560
[No Abstract] [Full Text] [Related]
3. Acyclovir-valaciclovir equilibrium between peritoneal fluid and plasma.
Stathoulopoulou F; Dhillon S; Stathakis C; Stamatiadis D
Perit Dial Int; 2001; 21(6):614-7. PubMed ID: 11783773
[No Abstract] [Full Text] [Related]
4. Valacyclovir and Acyclovir Neurotoxicity With Status Epilepticus.
Hoskote SS; Annapureddy N; Ramesh AK; Rose K; Jones JP
Am J Ther; 2016; 23(1):e304-6. PubMed ID: 24368610
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of acyclovir in the cat.
Owens JG; Nasisse MP; Tadepalli SM; Dorman DC
J Vet Pharmacol Ther; 1996 Dec; 19(6):488-90. PubMed ID: 8971679
[No Abstract] [Full Text] [Related]
6. Neurotoxicity of valacyclovir in peritoneal dialysis: a pharmacokinetic study.
Izzedine H; Mercadal L; Aymard G; Launay-Vacher V; Martinez V; Issad B; Deray G
Am J Nephrol; 2001; 21(2):162-4. PubMed ID: 11359026
[TBL] [Abstract][Full Text] [Related]
7. Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells.
Balimane P; Sinko P
Biopharm Drug Dispos; 2000 Jul; 21(5):165-74. PubMed ID: 11180195
[TBL] [Abstract][Full Text] [Related]
8. [Neurologic toxicity caused by zelitrex (valaciclovir) in 3 patients with renal failure. Is overdose associated with improvement of product bioavailability improvement?].
Peyrière H; Branger B; Bengler C; Vécina F; Pinzani V; Hillaire-Buys D; Blayac JP
Rev Med Interne; 2001 Mar; 22(3):297-303. PubMed ID: 11270274
[TBL] [Abstract][Full Text] [Related]
9. Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: An evaluation using ocular microdialysis and LC-MS.
Dias C; Nashed Y; Atluri H; Mitra A
Curr Eye Res; 2002 Oct; 25(4):243-52. PubMed ID: 12658558
[TBL] [Abstract][Full Text] [Related]
10. [Prodrugs].
Järvinen T; Rautio J; Niemi R
Duodecim; 1997; 113(24):2564-8. PubMed ID: 10892164
[No Abstract] [Full Text] [Related]
11. Vitreous penetration of orally administered valacyclovir.
Huynh TH; Johnson MW; Comer GM; Fish DN
Am J Ophthalmol; 2008 Apr; 145(4):682-6. PubMed ID: 18226802
[TBL] [Abstract][Full Text] [Related]
12. An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children.
Nadal D; Leverger G; Sokal EM; Floret D; Perel Y; Leibundgut K; Weller S
J Infect Dis; 2002 Oct; 186 Suppl 1():S123-30. PubMed ID: 12353197
[TBL] [Abstract][Full Text] [Related]
13. Valacyclovir neurotoxicity can be effectively managed by hemodialysis.
Kambhampati G; Pakkivenkata U; Kazory A
Eur J Neurol; 2011 Mar; 18(3):e33. PubMed ID: 21087359
[No Abstract] [Full Text] [Related]
14. Syntheses, chemical and enzymatic stability of new poly(ethylene glycol)-acyclovir prodrugs.
Zacchigna M; Di Luca G; Maurich V; Boccù E
Farmaco; 2002 Mar; 57(3):207-14. PubMed ID: 11989799
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of aciclovir after oral administration of aciclovir and its prodrug valaciclovir to patients with leukopenia after chemotherapy.
Steingrimsdottir H; Gruber A; Palm C; Grimfors G; Kalin M; Eksborg S
Antimicrob Agents Chemother; 2000 Jan; 44(1):207-9. PubMed ID: 10602752
[TBL] [Abstract][Full Text] [Related]
16. [Peptide transporter family].
Terada T; Inui K
Tanpakushitsu Kakusan Koso; 2001 Apr; 46(5):621-8. PubMed ID: 11296359
[No Abstract] [Full Text] [Related]
17. Case files of the Harvard Medical Toxicology Fellowship at Children's Hospital Boston: an insulin overdose.
Skolnik AB; Ewald MB
J Med Toxicol; 2010 Dec; 6(4):413-9. PubMed ID: 20725819
[No Abstract] [Full Text] [Related]
18. Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells.
Friedrichsen GM; Chen W; Begtrup M; Lee CP; Smith PL; Borchardt RT
Eur J Pharm Sci; 2002 Jul; 16(1-2):1-13. PubMed ID: 12113886
[TBL] [Abstract][Full Text] [Related]
19. A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like protein.
Kim I; Song X; Vig BS; Mittal S; Shin HC; Lorenzi PJ; Amidon GL
Mol Pharm; 2004; 1(2):117-27. PubMed ID: 15832508
[TBL] [Abstract][Full Text] [Related]
20. Valacyclovir-associated neurotoxicity in peritoneal dialysis patients.
Chaudhari D; Ginn D
Am J Ther; 2014; 21(6):e215-7. PubMed ID: 23528373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
